Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

Regulating Conception: Science, Politics, and Reproductive Genetic Innovation

by Myrisha S. Lewis
Save 17% Save 17%
Current price ₹5,001.00
Original price ₹6,002.00
Original price ₹6,002.00
Original price ₹6,002.00
(-17%)
₹5,001.00
Current price ₹5,001.00

Imported Edition - Ships in 18-21 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Hardcover
  • ISBN13: 9781479831524
  • Binding: Hardcover
  • Subject: N/A
  • Publisher: New York University Press
  • Publisher Imprint: New York University Press
  • Publication Date:
  • Pages: 264
  • Original Price: USD 45.0
  • Language: English
  • Edition: N/A
  • Item Weight: 545 grams
  • BISAC Subject(s): Medical Law & Legislation

Uncovers the hidden federal regulation of assisted reproductive technology and reproductive genetic innovation

The use of assisted reproductive technology (ART) has become increasingly prevalent in society, with approximately 42% of American adults reporting in 2023 that they or someone they know has undergone fertility treatment. Yet, while traditional ART techniques like artificial insemination or in vitro fertilization (IVF) have led to the birth of millions of children worldwide, their use and research has remained contested within the American regulatory sphere.

In Regulating Conception, Myrisha S. Lewis assesses the moral, political and social issues that influence the federal regulation of ART and reproductive genetic innovation. Contrasting the prevailing viewpoint that ART is "minimally regulated," Lewis uncovers how ART techniques that combine IVF with genetic modification or substitution face hidden regulations from federal agencies that curtail access to reproductive genetic innovation. Though the jurisdictional basis of these agency actions has never been clearly articulated, agency employees continue to use agency-issued letters and advisories to deter practitioners of reproductive genetic innovation. In doing so, these actions limit access to life-altering reproductive technologies in the United States and further disparities in access to assisted reproduction. Exposing the extent of over-regulation assisted reproduction in the US, Regulating Conception urges the minimal regulation of assisted reproduction and reproductive genetic innovation in place of clandestine regulation, to increase transparency and safeguard reproductive rights.

Trusted for over 49 years

Family Owned Company

Secure Payment

All Major Credit Cards/Debit Cards/UPI & More Accepted

New & Authentic Products

India's Largest Distributor

Need Support?

Whatsapp Us